Product Details
BUY MOUNJARO PENS UK
BUY MOUNJARO PENS UK
Mounjaro (tirzepatide)Â is a once-weekly, self-administered subcutaneous injection used to improve blood sugar control in adults with type 2 diabetes and for chronic weight management in adults with obesity or weight-related conditions. It works by activating GIP and GLP-1 receptors to reduce appetite and improve satiety. Common side effects include nausea, diarrhea, vomiting, and constipation.
BUY MOUNJARO PENS UK
Key Information on Mounjaro:
- Uses:Â Approved for Type 2 Diabetes (as an adjunct to diet and exercise) and chronic weight management.
- Administration:Â Injected under the skin (subcutaneously) of the abdomen, thigh, or upper arm once weekly at any time of day, with or without meals.
- Dosage:Â Starts at 2.5 mg for 4 weeks, increasing to 5 mg. Dose increases occur in 2.5 mg increments, maxing at 15 mg weekly.
- Side Effects:Â The most common side effects are gastrointestinal, including nausea, diarrhea, vomiting, abdominal pain, constipation, indigestion, and decreased appetite. Other potential issues include dizziness, fatigue, and gallbladder issues.
- Precautions:Â Mounjaro has not been studied in patients with a history of pancreatitis.
- Mechanism:Â It is a dual agonist, targeting both Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) receptors, which helps regulate blood sugar and slow gastric emptying, aiding in weight loss.
Additional information
| Dosage | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
|---|





